Four-week prevalence of mental disorders in patients with cancer across major tumor entities
Standard
Four-week prevalence of mental disorders in patients with cancer across major tumor entities. / Mehnert, Anja; Brähler, Elmar; Faller, Hermann; Härter, Martin; Keller, Monika; Schulz, Holger; Wegscheider, Karl; Weis, Joachim; Boehncke, Anna; Hund, Bianca; Reuter, Katrin; Richard, Matthias; Sehner, Susanne; Sommerfeldt, Sabine; Szalai, Carina; Wittchen, Hans-Ulrich; Koch-Gromus, Uwe.
In: J CLIN ONCOL, Vol. 32, No. 31, 01.11.2014, p. 3540-6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Four-week prevalence of mental disorders in patients with cancer across major tumor entities
AU - Mehnert, Anja
AU - Brähler, Elmar
AU - Faller, Hermann
AU - Härter, Martin
AU - Keller, Monika
AU - Schulz, Holger
AU - Wegscheider, Karl
AU - Weis, Joachim
AU - Boehncke, Anna
AU - Hund, Bianca
AU - Reuter, Katrin
AU - Richard, Matthias
AU - Sehner, Susanne
AU - Sommerfeldt, Sabine
AU - Szalai, Carina
AU - Wittchen, Hans-Ulrich
AU - Koch-Gromus, Uwe
N1 - © 2014 by American Society of Clinical Oncology.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - PURPOSE: To provide the 4-week prevalence estimates of mental disorders in cancer populations.PATIENTS AND METHODS: We enrolled adult patients with cancer from in- and outpatient care facilities, using a proportional stratified random sample based on the nationwide cancer incidence in Germany. Patients who scored 9 or above on the Patient Health Questionnaire (PHQ-9) were administered to the standardized computer-assisted Composite International Diagnostic Interview for mental disorders adapted for cancer patients (CIDI-O). A random sample of those with a PHQ-9 score that was less than 9 were selected for a CIDI-O.RESULTS: A total of 5,889 patients were identified, which led to 4,020 participants (a 68.3% response rate); of those, 2,141 patients were interviewed. The 4-week total prevalence for any mental disorder was 31.8% (95% CI, 29.8% to 33.8%); this included any anxiety disorder (11.5%; 95% CI, 10.2% to 12.9%), any adjustment disorder (11.1%; 95% CI, 9.7% to 12.4%), any mood disorder (6.5%; 95% CI, 5.5% to 7.5%), any somatoform/conversion disorder (5.3%; 95% CI, 4.3% to 6.2%), nicotine dependence (4.5%; 95% CI, 3.6% to 5.4%), alcohol abuse/dependence (0.3%; 95% CI, 0.1% to 0.6%), any mental disorder resulting from general medical condition (2.3%; 95% CI, 1.7% to 2.9%), and any eating disorder (0%). The highest prevalence for any mental disorder was found in patients with breast cancer (41.6%; 95% CI, 36.8% to 46.4%), followed by patients with head and neck cancer (40.8%; 95% CI, 28.5% to 53.0%). The lowest prevalence was found in patients with pancreatic cancer (20.3%; 95% CI, 8.9% to 31.6%) and stomach/esophagus cancers (21.2%; 95% CI, 12.8% to 29.6%).CONCLUSION: Our findings provide evidence for the strong need for psycho-oncological interventions.
AB - PURPOSE: To provide the 4-week prevalence estimates of mental disorders in cancer populations.PATIENTS AND METHODS: We enrolled adult patients with cancer from in- and outpatient care facilities, using a proportional stratified random sample based on the nationwide cancer incidence in Germany. Patients who scored 9 or above on the Patient Health Questionnaire (PHQ-9) were administered to the standardized computer-assisted Composite International Diagnostic Interview for mental disorders adapted for cancer patients (CIDI-O). A random sample of those with a PHQ-9 score that was less than 9 were selected for a CIDI-O.RESULTS: A total of 5,889 patients were identified, which led to 4,020 participants (a 68.3% response rate); of those, 2,141 patients were interviewed. The 4-week total prevalence for any mental disorder was 31.8% (95% CI, 29.8% to 33.8%); this included any anxiety disorder (11.5%; 95% CI, 10.2% to 12.9%), any adjustment disorder (11.1%; 95% CI, 9.7% to 12.4%), any mood disorder (6.5%; 95% CI, 5.5% to 7.5%), any somatoform/conversion disorder (5.3%; 95% CI, 4.3% to 6.2%), nicotine dependence (4.5%; 95% CI, 3.6% to 5.4%), alcohol abuse/dependence (0.3%; 95% CI, 0.1% to 0.6%), any mental disorder resulting from general medical condition (2.3%; 95% CI, 1.7% to 2.9%), and any eating disorder (0%). The highest prevalence for any mental disorder was found in patients with breast cancer (41.6%; 95% CI, 36.8% to 46.4%), followed by patients with head and neck cancer (40.8%; 95% CI, 28.5% to 53.0%). The lowest prevalence was found in patients with pancreatic cancer (20.3%; 95% CI, 8.9% to 31.6%) and stomach/esophagus cancers (21.2%; 95% CI, 12.8% to 29.6%).CONCLUSION: Our findings provide evidence for the strong need for psycho-oncological interventions.
KW - Cross-Sectional Studies
KW - Female
KW - Germany
KW - Humans
KW - Male
KW - Mental Disorders
KW - Middle Aged
KW - Neoplasms
KW - Prevalence
KW - Questionnaires
U2 - 10.1200/JCO.2014.56.0086
DO - 10.1200/JCO.2014.56.0086
M3 - SCORING: Journal article
C2 - 25287821
VL - 32
SP - 3540
EP - 3546
JO - J CLIN ONCOL
JF - J CLIN ONCOL
SN - 0732-183X
IS - 31
ER -